Clinical & Diagnostic
IVIS® Spectrum 2 and IVIS SpectrumCT 2imaging systems — new flagship platforms setting the standard in high-throughput performance and versat...
September 06, 2023 | News
The formal signing ceremony of the MoU was presided over by Farizal B. Jaafar, Acting Chief Executive Officer of MHTC, and Dr. Stacey Rizza, Mayo...
September 06, 2023 | News
Phase 3 innovaTV 301 confirmatory trial met its primary endpoint of improved overall survival (OS) at predetermined, independent interim analysis ...
September 05, 2023 | News
Oncology care innovator streamlines a notoriously fragmented healthcare system, reducing gaps and barriers to care for chronically under supp...
September 04, 2023 | News
Recruiting approximately 15,000 patients, MOONRAKER is expected to be one of the largest heart failure (HF) study programs to date1,2,3,4 Bayer continue...
September 01, 2023 | News
Six cohorts, totaling 50 late-stage cancer patients, received STP707 four times monthly by intravenous infusion at escalating dosages. All cohorts demon...
September 01, 2023 | News
PD-L1 IHC 22C3 pharmDx, Code SK006, is indicated as an aid in identifying certain cancer patients for treatment with KEYTRUDA® (pembrolizumab), Merck&r...
August 30, 2023 | News
“KeraLink International is unique in our singular focus on bringing health care providers, technology innovators, philanthropists, and investors into...
August 29, 2023 | News
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has granted marketing authorization for ABRYSVO™, the company’s bival...
August 25, 2023 | News
Thermo Fisher Scientific, a global leader in scientific services, announced the commercial launch of its EXENT solution after receiving IVDR certification*...
August 25, 2023 | News
The first patient, a 29-year-old woman from Australia who has suffered from debilitating headaches since the age of 14, experienced immediate and...
August 24, 2023 | News
Thermo Fisher Scientific, the world leader in serving science, announced the launch of a new chromosomal microarray designed to improve cytogenetic r...
August 23, 2023 | News
Paradigm Therapeutics Inc., a biopharmaceutical company, announced the completion of the acquisition of the worldwide rights of SD-101, a topical who...
August 23, 2023 | News
This strategic partnership will enable the integration of NGeneBio's advanced diagnostic assays with MGI's high-throughput sequencing technology to acceler...
August 23, 2023 | News
Most Read
Bio Jobs
News